[Incidence of hepatic changes in relation to the isoniazid acetylator phenotype].
作者信息
Pilheu J A, De Salvo M C, Manchinu I, de Negroni N R, Szemzo J
出版信息
Medicina (B Aires). 1980 Jul-Aug;40(4):382-6.
PMID:7207170
Abstract
摘要
相似文献
1
[Incidence of hepatic changes in relation to the isoniazid acetylator phenotype].
Medicina (B Aires). 1980 Jul-Aug;40(4):382-6.
2
The incidence of the acetylator phenotype of isoniazid in healthy and in pulmonary tuberculosis subjects in Bihar.
J Assoc Physicians India. 1978 May;26(5):353-60.
3
[The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
Cas Lek Cesk. 1984 Feb 10;123(6):158-64.
4
[The influence of rifampicin upon the metabolism of isoniazid (author's transl)].
Nouv Presse Med. 1978 Apr 15;7(15):1263-7.
5
[Determination of the phenotype of INH inactivation in pulmonary tuberculosis by means of an indirect method on the model of sulfamethazine].
Pneumonol Pol. 1978 Aug;46(8):605-12.
6
Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
Indian J Chest Dis Allied Sci. 1996 Jan-Mar;38(1):5-11.
7
Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
Int J Clin Pharmacol Res. 1984;4(2):141-4.
8
Incidence of isoniazid acetylation phenotypes in North Indians.
Int J Clin Pharmacol Ther Toxicol. 1984 May;22(5):259-64.
9
[Clinical pharmacology of isoniazid (a review of the literature)].
Probl Tuberk. 1979 Jan(1):18-26.
10
Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis.
Am Rev Respir Dis. 1984 Jan;129(1):58-61. doi: 10.1164/arrd.1984.129.1.58.
Zotero 插件